会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 36. 发明授权
    • Fluorescent proteins
    • 荧光蛋白
    • US08710195B2
    • 2014-04-29
    • US10567857
    • 2004-08-12
    • Satoshi Inouye
    • Satoshi Inouye
    • C07K1/13G01N33/533C07D241/00
    • C07K14/43595G01N21/76G01N33/84
    • A fluorescent protein (bFP) having chemiluminescence activity is a complex composed of the apoprotein of a calcium-binding photoprotein, coelenteramid or an analog thereof, and calcium ions or divalent or trivalent ions that can be substituted for the calcium ions. In the complex, the ratio of the number of molecules of the apoprotein to that of the coelenteramid is 1:1 and the ratio of the number of molecules of the apoprotein to that of the divalent or trivalent ions is 1:1 to 1:4. The fluorescent protein is used as a marker because it catalyzes luminescence of coelenterazine and has fluorescence capability. Removal of calcium ions etc. from this fluorescent protein (bFP) having luminescence activity provides a novel fluorescent protein (gFP). Mixing this gFP with the coelenterazine provides a calcium-binding photoprotein, which emit light instantaneously, enabling use as a marker.
    • 具有化学发光活性的荧光蛋白(bFP)是由钙结合光蛋白,coelenteramid或其类似物的脱辅基蛋白和可以代替钙离子的钙离子或二价或三价离子组成的复合物。 在络合物中,脱辅基蛋白的分子数与肠腔蛋白的分子数之比为1:1,脱辅基蛋白的分子数与二价或三价离子的分子数之比为1:1至1:4 。 荧光蛋白被用作标记物,因为它催化coelenterazine的发光并具有荧光能力。 从具有发光活性的荧光蛋白(bFP)中去除钙离子等提供新的荧光蛋白(gFP)。 将这种gFP与coelenterazine混合提供钙结合的光蛋白,其瞬时发光,可用作标记物。
    • 38. 发明申请
    • COELENTERAMIDE ANALOGS
    • 椰油胺类似物
    • US20110288280A1
    • 2011-11-24
    • US13146710
    • 2010-02-08
    • Takamitsu HosoyaKohei OkaSatoshi Inouye
    • Takamitsu HosoyaKohei OkaSatoshi Inouye
    • C07D241/20C07K2/00
    • C07D241/20C07K14/43595
    • There has been a need for coelenteramide analogs or the like that produce fluorescent proteins which exhibit different fluorescent characteristics from those of the existing fluorescent proteins. Disclosed is a compound represented by general formula (1) (wherein R1 represents a substituted or unsubstituted aryl, a substituted or unsubstituted arylalkyl, a straight or branched alkyl which may optionally be substituted with an alicyclic group, an alicyclic group or a heterocyclic group; R2 represents hydrogen or —(SO2)R4; R3 represents hydrogen, hydroxyl, methoxy or acetoxy; R4 represents a substituted or unsubstituted aryl, a substituted or unsubstituted arylalkyl or a straight or branched alkyl which may optionally be substituted with an alicyclic group; and X1 represents —C(═S)— or —SO2—).
    • 需要产生与现有荧光蛋白不同的荧光特性的荧光蛋白质的coelenteramide类似物等。 公开了由通式(1)表示的化合物(其中R 1表示取代或未取代的芳基,取代或未取代的芳烷基,可任选被脂环基,脂环基或杂环基取代的直链或支链烷基; R 2表示氢或 - (SO 2)R 4; R 3表示氢,羟基,甲氧基或乙酰氧基; R 4表示取代或未取代的芳基,取代或未取代的芳基烷基或可任选被脂环族基团取代的直链或支链烷基; X 1表示-C(= S) - 或-SO 2 - )。